Article
Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
medRxiv · 2022 · Stéphanie Thébault
Key facts
| Title | Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals |
|---|---|
| First author | Stéphanie Thébault |
| Journal | medRxiv |
| Published | May 11, 2022 |
| DOI | 10.1101/2022.05.10.491295 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K123955, K761172, K761173, K982382 |
| Product codes mentioned | CFN, JPA, NDS, OOI, PCA, DEW, JCI, JJH, KDT, KIP, KIT, MZF and 1 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1